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The Temporal and Spatial Dynamics of Foxp3þ
Treg Cell–Mediated Suppression during Contact
Hypersensitivity Responses in a Murine Model
Sari Lehtima¨ki1, Terhi Savinko1, Katharina Lahl2, Tim Sparwasser3, Henrik Wolff4, Antti Lauerma5,
Harri Alenius1 and Nanna Fyhrquist1
Regulatory T (Treg) cells suppress contact hypersensitivity (CHS) responses, but the dynamics, mode, and site of
their action is not well characterized. We studied forkhead box P3þ (Foxp3þ ) Treg cells during the CHS
response in conditional Foxp3 knockout depletion of regulatory T cell (DEREG) mice, where Foxp3þ cells can
be transiently deleted by diphtheria toxin. The mice were sensitized and challenged with oxazolone, and
Foxp3þ cells were depleted either during sensitization or elicitation. Treg cell depletion before sensitization
led to significantly exacerbated and prolonged CHS responses. In contrast, depleting Treg cells during
elicitation had no effect on the 24-hour response, but the response was significantly prolonged. In wild-type
mice, the gradual resolution of the CHS response was accompanied by a similarly gradual accumulation of
Foxp3þ Treg cells relative to T effector cells in the skin. This effect was not as marked in the Treg cell–depleted
mice, suggesting that the skin is an important site of Treg cell activities during the resolution phase. Together,
our results show that endogenous Foxp3þ Treg cell function is important during the sensitization and
resolution phases, but their depletion just before elicitation does not have an effect on the CHS response
during the first 24 hours after elicitation.
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INTRODUCTION
Allergic contact dermatitis is a common inflammatory skin
disease, caused by low-weight chemicals that behave like
haptens. Haptens bind to epidermal proteins and activate
antigen (Ag)-specific effector T (Teff) cells, which mediate
skin inflammation. Allergic contact dermatitis, which is also
referred to as contact hypersensitivity (CHS), usually requires
two distinct phases to achieve optimal immune reactions.
The sensitization phase occurs at the first contact with the
hapten, leading to the generation of Ag-specific T cells
that proliferate and circulate between the lymphoid organs
and the skin. During the elicitation phase, reexposure of
sensitized individuals leads to the activation of Ag-specific T
cells and the triggering of an inflammatory response, which
results in cutaneous lesions. To avoid excess tissue damage,
numerous regulatory mechanisms are activated during the
few days following hapten exposure, eventually leading to
resolution of the inflammatory response (Vocanson et al.,
2009).
CD8þ cytotoxic T cells are regarded as the main effector
cells in CHS responses, whereas CD4þ T cells function as
both effector and regulatory cells (Vocanson et al., 2009).
Although there are numerous regulatory pathways in the skin,
the downregulation of CHS is dominated by CD4þ
regulatory T (Treg) cells (Bour et al., 1995; Xu et al., 1996).
There is evidence that CD4þ Treg cells control both the
priming and expansion of Teff cells in the lymphoid organs,
and the activation of Teff cells in the skin (Dubois et al.,
2003; Kish et al., 2005; Tomura et al., 2010; Honda et al.,
2011). Thus, the regulatory mechanisms during CHS
responses can be divided into a central phase, restricting
the development of primed T cells, and a peripheral phase,
limiting inflammatory processes in the skin (Gorbachev and
Fairchild, 2001).
Treg cells are central in the maintenance of peripheral
tolerance and regulation of disease. A number of different
subsets have been described, including natural CD4þ
CD25þ Treg (nTreg) cells that specifically express transcrip-
tion factor forkhead box P3 (Foxp3) and develop in the
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thymus. In mice, Foxp3 controls the expression of multiple
genes that mediate the regulatory activity and is expressed
exclusively by Treg cells (Ziegler, 2006; Belkaid, 2007;
Vignali et al., 2008). Scurfy mice, which lack Foxp3, exhibit
several markers of disease, such as ear thickening and scaling
of the ears, lymphadenopathy, splenomegaly, and massive
lymphocytic infiltrates in the skin and liver. Besides
thymically derived Foxp3þ natural Treg cells, several other
T-cell populations have been assigned regulatory activity.
These so-called induced Treg (iTreg) cells may, or may not,
express Foxp3 and develop in the periphery following certain
modes of Ag presentation in the presence of cytokines such as
transforming growth factor-b and IL-10 (Shevach, 2006).
Numerous mechanisms of suppression have been described
for nTreg and iTreg cells, including the induction of Fas
ligand–dependent apoptosis, inhibition of IL-2 synthesis,
contact-dependent mechanisms, including CTLA-4, and
soluble mediators such as IL-10 and IL-35 (Shevach, 2006;
Vignali et al., 2008). However, little is known of the relative
contribution of the different Treg cell subsets, and their mode
and site of action in the control and resolution of CHS
responses.
To investigate how Foxp3þ nTreg and iTreg cells
contribute to the control of CHS responses, we deleted
Foxp3þ cells at selected time points in conditional Treg cell
knockout mice. Our results show that Foxp3þ Treg cell
function is critical both during the sensitization phase and
during the resolution of the response, through limiting the
Teff cell population. In contrast, deletion of Treg cells just
before elicitation had no effect on the 24-hour response.
RESULTS
Foxp3þ Treg cell depletion during the sensitization phase
significantly augments the inflammatory response
To assess the role of Foxp3þ Treg cells in restraining the
inflammatory response to oxazolone, we deleted Foxp3þ
cells during the sensitization phase by intraperitoneal
diphtheria toxin (DT) injections (Figure 1a) in depletion of
regulatory T cell (DEREG) mice that express a DT receptor
under the control of the Foxp3 promoter. In wild-type (WT)
mice, the number of Foxp3þ Treg cells relative to Foxp3–
CD4þ CD3þ cells remained at a steady level in the draining
lymph nodes (dLNs) throughout the CHS protocol. In the
DEREG mice, the DT treatment caused a rapid decline in
Foxp3þ Treg cell numbers, followed by a slow recovery
during the following 5 days. After challenge at day 5, Foxp3þ /
Foxp3 cell ratios rose at a faster rate (Figure 1b).
The depletion of Foxp3þ Treg cells before sensitization
resulted in considerable further swelling of the ears 24 hours
after challenge, and in hematoxylin and eosin–stained tissue
the epidermis was significantly thicker and the skin heavily
populated by infiltrated neutrophils and T cells (Figure 1c and
d). The DT treatment alone led to significantly increased
numbers of eosinophils in the skin in the DEREG mice
compared with the WT; however, after allergen challenge,
their numbers did not notably differ from that in the WT
(Figure 1e). Finally, the expression level of inflammatory
mediators IFN-g, IL-10, CXCL9, and CXCL10 was considerably
higher at the mRNA level in the DEREG mice compared with
WT mice (Figure 1f).
Foxp3þ Treg cell depletion during the elicitation phase has no
effect on the 24-hour response
During the elicitation phase, memory T cells are activated
both in the skin and in the LNs, leading to fast mobilization of
effector cells and efficient elaboration of an inflammatory
response (Traidl et al., 2000; Vocanson et al., 2009). To test
the role of Foxp3þ Treg cells during the elicitation process,
we deleted Foxp3þ cells 1 day before oxazolone challenge
(Figure 2a and b), and quite surprisingly the abrupt absence of
Foxp3þ Treg cells had no effect on the 24-hour response
(Figure 2c–f).
Foxp3þ Treg cells are essential in the resolution of cutaneous
inflammation
The CHS response begins to resolve within a few days
following exposure to contact allergens, as a consequence of
the activation of immunosuppressive mechanisms (Vocanson
et al., 2009). In the WT mice, the ear swelling response
peaked at 24 hours, and returned to near baseline by 96 hours
after challenge in perfect concert with the expression of
inflammatory mediators IFN-g, CXCL9, CXCL10, and IL-10
(Figure 3a and b). The infiltration of CD8þ cells (Figure 3c)
and neutrophils and eosinophils (Supplementary Figure S1
online) peaked at 48 hours, yet the recruitment of CD3þ and
CD4þ cells increased steadily throughout the period of 96
hours (Figure 3c) and Foxp3þ Treg cells accumulated
gradually in the skin (Figure 3d). The suppressive function
of Foxp3þ T cells isolated from dLNs of sensitized and
challenged mice was confirmed by in vitro suppression
assays with Foxp3 T cells at various ratios from the same
mice as responders (Supplementary Figure S2 online).
The depletion of Foxp3 Treg cells before sensitization led
to a greatly exaggerated and prolonged CHS response (Figure
3a and b). As in the WT mice, the infiltration of CD3þ
CD4þ cells increased throughout the 96-hour period (Figure
3c), but in great contrast the share of Foxp3þ Treg cells
entering the skin was much smaller in the DT-treated DEREG
mice (Figure 3d). However, in the dLNs in the DEREG mice,
the ratio of Foxp3þ to Foxp3 CD3þ CD4þ cells had
returned to the normal by 96 hours after challenge (Figure 3e).
In the mice that were depleted of Foxp3þ cells before
challenge, the CHS response at 24 hours was identical to that
in WT mice. At later time points, however, the resolution of
the response was significantly delayed and the infiltration of
CD3þ cells ever growing (Figure 3a–c). As could be
expected after the recent DT treatment, the number of
Foxp3þ Treg cells was low both in the skin and in the dLNs
(Figure 3d and e).
Foxp3þ cell depletion results in increased expression of
costimulatory molecules, T-cell proliferation, and activation
Treg cells suppress inflammation through regulating the
activation and expansion of T effector cells (Vignali et al.,
2008). Depleting Foxp3þ Treg cells at the time of sensitiza-
tion led to larger numbers of proliferating (Ki67þ ) and
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activated (CTLA4þ ) CD4þ and CD8þ T cells in the LNs at
all-time points examined after challenge (Figure 4). In
contrast, depleting Treg cells before elicitation did not have
any effects on the activation or proliferation of CD4þ T cells
at 24 hours. However, these parameters increased signifi-
cantly at later time points (Figure 4). It is noteworthy that the
level of CD8þ T-cell activation was increased already at 24
hours after challenge (Figure 4b), representing the first sign of
modulation by the deletion of Treg cells before elicitation.
The expression of costimulatory molecules on Ag-present-
ing cells correlates with their capacity to activate T cells, and
Treg cells regulate immune functions by suppressing their
expression. In the mice that were depleted of Foxp3þ Treg
cells during the sensitization phase, the expression of CD80
or CD86 on CD11cþ dendritic cells in the dLNs and in the
skin was increased at 24 hours after challenge compared with
the WT mice (Figure 5a and Supplementary Figure S3 online),
and remained at an elevated level at 48 and 96 hours after
challenge (Figure 5a). In contrast, in the mice that were
depleted of Treg cells before elicitation, the expression of
costimulatory molecules was normal at 24 hours after
challenge, and started rising only at later time points,
particularly in the skin (Figure 5 and Supplementary Figure
S3 online).
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Figure 1. Effects of forkhead box P3 (Foxp3+) cell depletion during sensitization phase. (a) Mice were treated with diphtheria toxin (DT) 1 day before
sensitization. (b) The percentages of Foxp3þ cells among CD4þ T cells were determined in the draining lymph nodes (dLNs) by flow cytometry at various time
points after sensitization and challenge. (c) Representative images of hematoxylin and eosin (H&E)–stained ear tissue of vehicle-treated and oxazolone-sensitized
and challenged wild-type (WT) and depletion of regulatory T cell (DEREG) mice. Scale bar¼100 mm. (d) Ear swelling, (e) cellular infiltration, and (f) expression
of several cytokines were significantly upregulated in DEREG mice compared with WT. *Po0.05; **Po0.01; ***Po0.001; bars represent mean±SD. HPF,
high-power field; OXA, oxazolone (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one); RU, relative units; sensDT, DT treatment prior to sensitization group; VEH,
vehicle.
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DISCUSSION
To compare the relative importance of intact Foxp3þ Treg
cell function during the sensitization versus the elicitation
phase, we depleted DEREG mice of Foxp3þ cells by
administering DT either 1 day before sensitization (sensDT
DEREG mice) or 1 day before elicitation (elicDT DEREG
mice). The lack of Foxp3þ Treg cells during sensitization
had a marked effect on the extent of inflammation after
challenge. Both the strength and duration of inflammation
were significantly enhanced in the sensDT DEREG mice
compared with the WT, with highly proliferating and
activated T cells and dendritic cells in the skin and dLNs.
The sensDT DEREG mice had increased levels of effector
cells compared with WT controls, as the absence of Treg cells
enhances the activation of hapten-specific cells. In addition,
the level of Foxp3þ T cells remained low until challenge,
likely contributing further to the increase in the CHS response
at 24 hours in the sensDT mice. Surprisingly, the depletion of
Foxp3þ Treg cells 1 day before elicitation had no effect on
the CHS response at 24 hours after challenge. A similar
observation has been made in mice injected with anti-CTLA-
4 (Nuriya et al., 2001), which blocks central mechanisms of
Treg cell–mediated suppression (Wing and Sakaguchi, 2010),
and Tomura et al. (2010) reported just a small effect on the
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Figure 2. Effects of forkhead box P3 (Foxp3+) cell depletion during elicitation phase. (a) Mice were treated with diphtheria toxin (DT) one day before
elicitation. (b) The percentages of Foxp3þ cells were determined in the draining lymph nodes (dLNs) by flow cytometry at various time points after
sensitization and challenge. (c) Representative images of hematoxylin and eosin (H&E)–stained ear tissue of vehicle-treated and oxazolone-sensitized and
challenged wild-type (WT) and depletion of regulatory T cell (DEREG) mice. Scale bar¼ 100mm. (d) At 24 hours after challenge, the ear swelling response,
(e) cellular infiltration, and (f) expression levels of several cytokines were all at levels similar to those of the WT mice. HPF, high-power field; elicDT, DT
treatment prior to elicitation group; OXA, oxazolone (4-ethoxymethylene-2-phenyl-2-oxazolin-5-one); RU, relative units; VEH, vehicle.
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24-hour ear-swelling response after depleting Foxp3þ Treg
cells at the time of challenge. A likely explanation is that the
elicDT DEREG mice that were depleted of Treg cells before
elicitation had comparable levels of effector cells as WT
controls, and it may take time for effector cells to add their
forces after having been unleashed from Treg cell control.
Indeed, in the elicDT mice the CHS response increased at
later time points. Similarly, it may take time for Treg cells to
have a significant suppressive effect on effector cells, which
we observed in the WT controls, where suppression of the
CHS response did not begin until at 48 hours after challenge.
Together, the results underline the importance of Foxp3þ
Treg cell activities both in priming and terminating the T-cell
response, in accordance with recently published observations
(Tomura et al., 2010; Honda et al., 2011).
Although our results suggest that fast-acting mechanisms
of suppression might not be important in the regulation of
normal CHS responses, we cannot exclude the fact that any
such mechanisms may have a role in therapeutic applica-
tions, such as the transfer of external regulatory cells. Indeed,
in adoptive transfer studies, the injection of Treg cells as late
as 15 minutes before challenge led to efficiently suppressed
CHS responses. The injected Treg cells did not enter the skin,
but remained in the circulation and mediated suppression
through blocking the influx of effector cells at the site of
challenge (Ring et al., 2009).
The regulation of CHS is on one hand concerned with
limiting the expansion of Teff cells in the LNs, and on the
other hand with limiting the inflammatory process in the skin
(Gorbachev and Fairchild, 2001). The site of action of
Foxp3þ Treg cells in CHS is, however, not clear. We show
that during the resolution phase Foxp3þ Treg cells
accumulate gradually in the skin relative to Foxp3 T cells,
constituting a large portion of the CD4þ T-cell population in
the skin at 96 hours after challenge. The accumulation of Treg
cells coincided with an equally gradual fading of the ear
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Figure 3. Resolution of inflammation was impaired after forkhead box P3þ (Foxp3+) cell depletion. (a) Ear swelling response peaked at 24 hours after
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swelling response and the expression of inflammatory
mediators. In contrast, when Treg cells failed to accumulate
and outnumber effector cells in the skin, the resolution of the
inflammatory response was significantly delayed, which was
the case in the Treg cell–deleted mice. In the DEREG mice
that were DT-treated before sensitization, the recruitment of
Treg cells relative to Teff cells to the skin was highly
defective, probably because of the fact that the great majority
of the regenerated Foxp3þ cell population had encountered
the allergen only once, during the elicitation phase. By
analogy, externally transferred UV-induced Treg cells accu-
mulate in the LNs, do not enter the skin, and are unable to
suppress the effector response, unless the recipient is
repeatedly exposed to the agent that causes skin inflamma-
tion, or Treg cells are injected into the area of challenge
(Schwarz et al., 2004). Furthermore, Tomura et al. (2010)
observed that Treg cells continuously circulate between the
skin and the LNs during cutaneous immune responses, and
this migrating subset of Treg cells holds particular suppressive
potential compared with Treg cells residing in the LNs. The
importance of sufficient Treg cell recruitment and function in
the skin has been underlined in other skin conditions, such as
human vitiligo (Klarquist et al., 2010) and rare autoimmune
diseases (Hanafusa et al., 2011) involving the activation of
cytotoxic T lymphocytes as a consequence of the paucity of
Treg cells. Thus, the skin seems to have an important role in
the generation and education of Treg cells, and is an
important site of action for the regulatory mechanisms that
eventually lead to the termination of CHS.
Treg cells utilize a plethora of mechanisms to down-
regulate immune responses, including suppression by in-
hibitory cytokines, induction of cytolysis or metabolic
disruption, or modulation of dendritic cell maturation or
function. Foxp3þ Treg cells constitutively express CTLA-4,
and the lack of CTLA-4 impairs their suppressive function,
suggesting that it is a core mechanism of Treg cell–mediated
suppression. A key role of CTLA-4-dependent suppression is
the downmodulation of Ag-presenting cell function, including
CD80 and CD86 expression (Wing et al., 2008). We observed
upregulated levels of CD80 and CD86 both in the dLNs and in
the skin in the mice that were depleted of Foxp3þ Treg cells
during sensitization. In the mice that were depleted of
Foxp3þ cells during elicitation, CD80 and CD86 expression
in the skin was at the same level as that in WT mice at 24
hours after challenge, but then progressively increased
through later time points, as a consequence of lacking Treg
cells. In contrast, the expression of suppressive cytokine IL-10
was independent of the presence of Foxp3þ Treg cells,
indicating that IL-10 was produced by sources other than
Foxp3þ Treg cells. Indeed, a number of studies have shown
that IL-10 production by Treg cells is not essential for the
prevention of inflammation (Vignali et al., 2008).
Prominent eosinophilia has been observed in the skin in
mice with a loss-of-function mutation in the Foxp3 gene (Lin
et al., 2005). Similarly, in our study, there were increased
numbers of eosinophils in the skin in DT-treated DEREG
control mice compared with WT. However, after allergen
challenge, the extent of eosinophilia was identical between
the WT and the DEREG mice, indicating that although
Foxp3þ cells may be important in the control of eosinophilia
at the steady state they do not directly control the influx of
eosinophils during inflammation.
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To conclude, we show that endogenous Foxp3þ Treg
cells are critically involved in the regulation of T-cell priming
and the termination of the CHS response. The skin is an
important site of regulation, and if the recruitment of Treg
cells to the skin is defective, the consequence is a delayed
resolution of the inflammatory response. Our results empha-
size the importance of designing future immunotherapy that
specifically targets the affected site.
MATERIALS AND METHODS
Mice
DEREG mice on a C57BL/6 background (Lahl et al., 2007) were
kindly provided by Dr Tim Sparwasser (Institute of Infection
Immunology, Hannover, Germany) and bred in our facilities. The
mice were used in experiments at 12–14 weeks of age. All animal
protocols were approved by Health Services of State Provincial
Office of Southern Finland.
Animal treatment protocol
Mice were sensitized on the shaved backs with 1% oxazolone on
day 0, and challenged with 0.3% oxazolone on both ears on day 5,
followed by sample collection and analysis 24 hours later, on day 6.
In the resolution phase studies, samples were collected 24, 48, or 96
hours after challenge. The experiments were repeated three times,
with 5–8 mice per group. Ear thickness was measured with a
micrometer (Mitutoyo, Kanagawa, Japan) at 24, 48, and 96 hours
after challenge, after which ear dLNs and ears lobes were collected
for further analysis.
DT treatment
Treg cells were depleted from DEREG mice by intraperitoneal
injection of DT (50mg kg–1 body weight; Calbiochem, La Jolla, CA)
on day –1 (before allergen sensitization) or on day 4 (before allergen
challenge). DEREG mice express a DT receptor under the control
of Foxp3 promoter, allowing for transient and specific depletion
of Foxp3þ Treg cells. For control purposes, WT mice also
received DT.
Histology
For histology, paraffin-embedded ear tissue samples were hematox-
ylin and eosin stained, and examined for inflammatory cell
infiltrates. Cells were counted in 15 high-power fields at  1,000
magnification and expressed as cells per high-power field. Frozen
ear tissue sections were peroxidase stained with rat anti-mouse CD3,
CD4, or CD8 antibodies (BD Biosciences, San Jose, CA) and biotin-
conjugated secondary Ab anti-rat IgG (Hþ L) (Vector Laboratories,
Servion, Switzerland).
Measurements of mRNA expression
RNA extraction from frozen ear tissue samples was performed
according to Trisure instructions (Bioline, London, UK). Extracted
RNA was reverse transcribed into complementary DNA using
MultiScribe reverse transcriptase and random hexamers (Applied
Biosystems, Foster City, CA). Real-time quantitative PCR was
performed with 7500 Fast Real-Time PCR system (Applied Biosystems)
as described previously (Lehto et al., 2005). PCR primers and target-
specific probes were purchased as predeveloped reagents. Endoge-
neous 18S ribosomal RNA was used as the housekeeping gene.
Flow cytometry
Single-cell suspensions from the ear tissue were prepared by cutting
the skin sample into small pieces, passing through a 70-mm cell
strainer, washing with phosphate-buffered saline, and filtering again
through a 40-mm cell strainer (BD Biosciences). LN cells were
isolated by crushing the nodes and filtering through a 100-mm
strainer. Antibodies phycoerythrin (PE)-Cy7-conjugated anti-CD3
(BD Biosciences), PerCP-Cy5-conjugated anti-CD4, Alexa Fluor
700–conjugated anti-CD8, allophycocyanin-Alexa750-conjugated
CD11c, PE-conjugated anti-CD86, and allophycocyanin-conjugated
anti-CD80 (eBiosciences, San Diego, CA) were used for surface
stainings. For intracellular stainings of Foxp3 and Ki-67, cells were
fixed and permeabilized with a commercial Foxp3 staining kit
(eBiosciences) and the cells were stained with PE-conjugated anti-
Foxp3, Alexa Fluor 700-conjugated anti-Foxp3, or PE-conjugated
anti-Ki-67 (BD Biosciences). For intracellular staining of CTLA-4, Fix
and Perm kit from Invitrogen (Camarillo, CA) was used and the cells
were stained with PE-conjugated anti-CTLA-4 (eBiosciences).
Samples were run with FacsCantoII (BD Biosciences) and results
analyzed with the FlowJo software (Tree Star, Ashland, OR).
Suppression assay
CD4þ T cells from the dLNs of oxazolone-sensitized and
challenged DEREG mice were purified with the Robosep CD4þ
cell positive selection kit (StemCell Technologies, Grenoble, France)
and sorted into enhanced green fluorescent protein (EGFP)þ
(BFoxp3þ ) and EGFP (BFoxp3) cells with FACS Aria (BD
Biosciences). In all, 3 104 responder cells (CD4þ Foxp3) were
cultured with 0, 3 104, or 6 104 CD4þ Foxp3þ cells in the
presence of a-CD3 (0.75 mgml–1) and a-CD28 (2.5 mgml–1) for 72
hours, after which 1mCi [3H] thymidine per well (Amersham
Biosciences Europe, Freiburg, Germany) was added and the
incubation continued for 18 hours. Incorporated radioactivity was
determined using a liquid scintillation counter (Trilux 1450
Microbeta, Wallac, Turku, Finland). Results are expressed as mean
counts per minute of triplicate wells.
Statistical analysis
Student’s t-test was used to analyze the data, after passing normality
and equal variance tests. The data are expressed as mean values
±SD. *Po0.05; **Po0.01; and ***Po0.001.
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